CNBX Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $1.8M | $777.6K |
| FY2021 | — | $1.8M | $1.4M |
| FY2022 | — | $1.6M | $117.5K |
| FY2023 | — | $-2.0M | $129.7K |
| FY2024 | — | $-2.5M | $26.4K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $1.8M | $777.6K |
| FY2021 | — | $1.8M | $1.4M |
| FY2022 | — | $1.6M | $117.5K |
| FY2023 | — | $-2.0M | $129.7K |
| FY2024 | — | $-2.5M | $26.4K |